Hyperthermia and Mitomycin C, Bacillus Calmette-Guerin, or Standard Therapy as Second-Line Therapy in Treating Patients With Recurrent Bladder Cancer

NCT01094964 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

242

Enrollment

OTHER

Sponsor class

Conditions

Bladder Cancer

Interventions

BIOLOGICAL: BCG solution
BIOLOGICAL: recombinant interferon alfa
DRUG: epirubicin hydrochloride
DRUG: mitomycin C
OTHER: laboratory biomarker analysis
PROCEDURE: hyperthermia treatment
PROCEDURE: quality-of-life assessment

Sponsor

Cancer Research Campaign Clinical Trials Centre